Family Dollar is initiating a voluntary retail-level product recall of certain over-the-counter drugs and medical devices regulated by the FDA. These items were stored outside of labeled temperature requirements by Family Dollar and inadvertently shipped to certain stores on or around June 1, 2023 through September 21, 2023. These items were sold at those stores between June 1, 2023 and October 4, 2023.
To date, Family Dollar has not received any consumer complaints or reports of illness related to this voluntary recall. This recall is being conducted out of an abundance of caution.
A list of the recalled products is here. This recall goes to the retail store level. Not all of the products listed were sent to all stores.
Family Dollar has notified its affected stores asking them to check their stock immediately and to quarantine and discontinue the sale of any affected product. Customers who purchased affected product may return such product to the Family Dollar store where they were purchased without receipt. This recall only applies to the following 23 states as no Family Dollar stores in any of the other states received any products subject to this recall: AL, AR, AZ, CA, CO, FL, GA, ID, KS, LA, MS, MT, ND, NE, NM, NV, OK, OR, SD, TX, UT, WA, and WY.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!